Overview
BRVE market data
Price History
BRVE price chart · 1M
- O
- 25.64
- H
- 27.15
- L
- 25.53
- C
- 26.63
- Vol
- 13,534.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $25.64
- Previous Close
- $26.23
- Day High
- $27.15
- Day Low
- $25.53
- 52 Week High
- $31.82
- 52 Week Low
- $24.41
- 7 Day Return
- -3.06%
- 30 Day Return
- -12.70%
- 90 Day Return
- -12.70%
- 1 Year Return
- -12.70%
- Daily Notional Volume
- $360.4K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.87 Diluted earnings per share over the trailing twelve months.
- Beta
- -3.63 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $24.31 – $32.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2B.
Company News
10 captured
This Airbnb Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayBenzinga ·
Goldman Sachs Initiates Coverage On Braveheart Bio with Buy Rating, Announces Price Target of $48Benzinga ·
Jefferies Initiates Coverage On Braveheart Bio with Buy Rating, Announces Price Target of $48Benzinga ·
This Lumentum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga ·
Stifel Initiates Coverage On Braveheart Bio with Buy Rating, Announces Price Target of $45Benzinga ·
Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors?The Motley Fool ·
8-K filing — Braveheart Bio, Inc. (BRVE)SEC EDGAR ·